Bulletin Contents
Search
Home Page
 
*Cotinga Pharmaceuticals Inc 
Listed Company 

CRITICAL OUTCOME TECHNOLOGIES INC. ("COT")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: October 25, 2017
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing documentation with respect to a Non-Brokered Private Placement announced Sep 12, 2017:

Number of Shares: 1,771,124 shares

Purchase Price: $1.16 per share

Warrants: 1,771,124 share purchase warrants to purchase 1,771,124 shares

Warrant Initial Exercise Price: $1.21

Warrant Term to Expiry: 1 Year

Number of Placees: 53 Placees

Insider / Pro Group Participation:
Insider=Y /
Name Pro-Group=P # of Shares
John Drake Y 86,207
Alison Silva Y 43,100
Bruno Maruzzo Y 4,400
Douglas Alexander Y 13,000
Gene Kelly Y 8,600
John Yoo Y 4,400
David Sanderson Y 4,400
Aggregate Pro-Group Involvement [2 Placees] P 30,000

Finder's Fee:
Canaccord Genuity Corp. $25,359.46 cash; 21,861 warrants
Industrial Alliance Securities $10,788.00 cash; 9,300 warrants
CIBC World Markets Inc. $13,920.00 cash; 12,000 warrants
Clement Messere $2,099.97 cash; 1,810 warrants
Peter Messere $2,992.80 cash; 2,580 warrants
Echelon Wealth Partners Inc. $1,044.00 cash; 900 warrants
Red Jacket Capital Inc. $3,480.00 cash; 3,000 warrants
Marco Durante $1,740.00 cash; 1,500 warrants
Wellington-Altus Private Wealth Inc. $9,152.40 cash; 7,890 warrants

Finder Warrant Initial Exercise Price: $1.21

Finder Warrant Term to Expiry: Expire 12 months from the date of issue, may be accelerated as with Warrants issued under offering

Note that in certain circumstances the Exchange may later extend the expiry date of the warrants, if they are less than the maximum permitted term.

The above information is a summary only. Neither TMX Group Limited nor any of its affiliated companies guarantee the accuracy or completeness of the information contained in this document. Readers should consult the issuer's continuous disclosure record for complete details of the transaction.
________________________________________